Thermo Fisher partners EDB for US$130m sterile fill-and-finish facility
Singapore
THERMO Fisher Scientific's plans to build a new US$130 million sterile fill-and-finish facility in Singapore, with the support of the Singapore Economic Development Board (EDB), will create some 300 jobs once operational in 2022.
The investment is an "important addition to the manufacturing capacity needed by global pharmaceutical and vaccine companies in the ongoing fight against Covid-19," EDB chairman Beh Swan Gin said in a press release late last week.
TRENDING NOW
PSD reviewing paper that alleges civil servants disproportionately bought homes near unannounced MRT stations
CapitaLand Investment’s retrenchments: Mind the downsides of a profitable business laying off staff
In a business takeover, how can landlords in Singapore protect themselves?
How Asia’s next generation is rewriting legacy through entrepreneurship